FDA Sends Mixed Message On Labeling Authority: Is Website Enough?

FDA's planned "Drug Watch" website could render proposals to give the agency authority to mandate drug labeling changes and postmarketing safety studies unnecessary, FDA Acting Deputy Commissioner for Operations Janet Woodcock told the Senate Health Committee